Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Ousted OpenAI head Sam Altman to lead Microsoft’s new AI team
Former OpenAI CEO Sam Altman will be joining Microsoft to lead a new advanced AI research team, according to Microsoft CEO Satya Nadella. Post Views: 139
UK debt chief says demand back after mini-budget debacle
Post Content Post Views: 111
Dollar stumbles to over two-month low as markets eye Fed cuts
Post Content Post Views: 150
Israel stocks higher at close of trade; TA 35 up 0.26%
Post Content Post Views: 117
Some OpenAI customers are thinking about switching to rivals amid chaos
Some OpenAI clients are seeking alternatives since the drama unfolded with the ousting of CEO Sam Altman. Post Views: 133
Wall St ends mixed in truncated Black Friday trading
Post Content Post Views: 131